The impact of chemotherapy on the survival of patients with metastatic urothelial tumors.
Department of Medical Oncology, University of Texas M. D. Anderson Cancer Center, Houston 77030.
C J
CJ
Logothetis
F H
FH
Dexeus
C
C
Chong
A
A
Sella
S
S
Ogden
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D004341:Drug Evaluation; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000401:mortality; D009378:Neoplasms, Multiple Primary / Q000401:mortality; D016032:Randomized Controlled Trials as Topic; D012189:Retrospective Studies; D012307:Risk Factors; D015996:Survival Rate; D013781:Texas / Q000453:epidemiology; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000601:surgery
D004317:Doxorubicin; D003520:Cyclophosphamide; D002945:Cisplatin